Branch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.
Status:
Not yet recruiting
Trial end date:
2021-09-17
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the visual outcome and prognostic factors after
intraocular injections of Bevacizumab or combination of Bevacizumab And Dexamethasone under
pro re nata treatment regimen for Branch Retinal Vein Occlusion (BRVO) patients.